QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Forecast, Price & News

$8.46
-0.09 (-1.05%)
(As of 06/7/2023 ET)
Compare
Today's Range
$8.44
$8.73
50-Day Range
$7.19
$8.55
52-Week Range
$4.22
$10.50
Volume
1.04 million shs
Average Volume
591,634 shs
Market Capitalization
$3.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.04

LifeStance Health Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
4.9% Downside
$8.04 Price Target
Short Interest
Bearish
9.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$1.74 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.29) to ($0.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.18 out of 5 stars

Medical Sector

952nd out of 981 stocks

Health Services Industry

13th out of 13 stocks


LFST stock logo

About LifeStance Health Group (NASDAQ:LFST) Stock

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform, as well as offers patients care virtually through its online delivery platform or in-person at its centers in 33 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

LFST Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Goldman Sachs Remains a Hold on Lifestance Health Group (LFST)
LifeStance Health Group Inc Ordinary Shares
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Q1 2023 Lifestance Health Group Inc Earnings Call
LifeStance Reports First Quarter 2023 Results
See More Headlines

LFST Price History

LFST Company Calendar

Last Earnings
5/10/2023
Today
6/07/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFST
Fax
N/A
Employees
7,830
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.04
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$7.25
Forecasted Upside/Downside
-5.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-215,560,000.00
Pretax Margin
-22.22%

Debt

Sales & Book Value

Annual Sales
$859.54 million
Book Value
$4.04 per share

Miscellaneous

Free Float
344,740,000
Market Cap
$3.21 billion
Optionable
Not Optionable
Beta
0.88

Key Executives

  • Mr. Kenneth Alan Burdick (Age 64)
    CEO & Chairman
    Comp: $624.22k
  • Mr. Danish J. Qureshi (Age 38)
    Pres & COO
    Comp: $342.2k
  • Mr. David Patrick Bourdon (Age 53)
    Chief Financial Officer & Treasurer
    Comp: $368.6k
  • Ms. Monica Prokocki
    VP of Investor Relations
  • Mr. Ryan Pardo (Age 47)
    Chief Legal Officer & Sec.
  • Brooke Matthews
    Director of PR
  • Ms. Ann Varanakis (Age 45)
    Chief People Officer
  • Mr. Pablo Pantaleoni (Age 35)
    Chief Digital Officer
  • Mr. Kevin Michael Mullins (Age 38)
    Chief Devel. Officer
  • Dr. Anisha Patel-Dunn D.O. (Age 47)
    Chief Medical Officer













LFST Stock - Frequently Asked Questions

Should I buy or sell LifeStance Health Group stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LFST shares.
View LFST analyst ratings
or view top-rated stocks.

What is LifeStance Health Group's stock price forecast for 2023?

6 brokers have issued 1-year price targets for LifeStance Health Group's shares. Their LFST share price forecasts range from $7.25 to $9.00. On average, they expect the company's stock price to reach $8.04 in the next twelve months. This suggests that the stock has a possible downside of 5.6%.
View analysts price targets for LFST
or view top-rated stocks among Wall Street analysts.

How have LFST shares performed in 2023?

LifeStance Health Group's stock was trading at $4.94 at the beginning of 2023. Since then, LFST stock has increased by 72.5% and is now trading at $8.52.
View the best growth stocks for 2023 here
.

When is LifeStance Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our LFST earnings forecast
.

How were LifeStance Health Group's earnings last quarter?

LifeStance Health Group, Inc. (NASDAQ:LFST) announced its earnings results on Wednesday, May, 10th. The company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The company earned $252.59 million during the quarter, compared to the consensus estimate of $246.04 million. LifeStance Health Group had a negative net margin of 20.63% and a negative trailing twelve-month return on equity of 12.32%.

What ETFs hold LifeStance Health Group's stock?
What guidance has LifeStance Health Group issued on next quarter's earnings?

LifeStance Health Group issued an update on its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $250.00 million-$260.00 million, compared to the consensus revenue estimate of $250.46 million.

When did LifeStance Health Group IPO?

(LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is LifeStance Health Group's stock symbol?

LifeStance Health Group trades on the NASDAQ under the ticker symbol "LFST."

Who are LifeStance Health Group's major shareholders?

LifeStance Health Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (6.85%), BlackRock Inc. (1.38%), Principal Financial Group Inc. (0.98%), Geode Capital Management LLC (0.49%), State Street Corp (0.39%) and O Brien Wealth Partners LLC (0.22%). Insiders that own company stock include Anisha Patel-Dunn, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk.
View institutional ownership trends
.

How do I buy shares of LifeStance Health Group?

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeStance Health Group's stock price today?

One share of LFST stock can currently be purchased for approximately $8.52.

How much money does LifeStance Health Group make?

LifeStance Health Group (NASDAQ:LFST) has a market capitalization of $3.21 billion and generates $859.54 million in revenue each year. The company earns $-215,560,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis.

How many employees does LifeStance Health Group have?

The company employs 7,830 workers across the globe.

How can I contact LifeStance Health Group?

The official website for the company is www.lifestance.com. The company can be reached via phone at 602-767-2100.

This page (NASDAQ:LFST) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -